Investment Rating - The report maintains a "Buy" rating for both JD Health and Meituan, indicating a positive outlook for their stock performance in the healthcare sector [5][22]. Core Insights - The pharmaceutical retail O2O market in China is characterized by strong competition, with Meituan being the largest player due to its delivery capabilities and early market entry in 2013. JD Health is emerging as a significant competitor with advantages in supply chain and asset-heavy business model [2][4]. - Meituan's healthcare product GMV is estimated to reach approximately Rmb45 billion in 2023, with a target growth rate of at least 30% annually. The majority of its healthcare-related GMV comes from O2O sales [2][3]. - JD Health's asset-heavy model may provide a competitive edge in the healthcare industry, as many services require offline provision and have higher logistics demands. JD Health's scale gives it stronger bargaining power with suppliers [4][5]. Summary by Sections Meituan's Position - Meituan has captured a significant share of the pharmacy market, with around 250,000 pharmacies operating on its platform. The company aims to expand its healthcare segment despite challenges in driving growth due to market saturation [2][3]. - The expert suggests potential strategies for Meituan to enhance growth, including integration with the medical beauty segment and lobbying for reimbursement of O2O drug orders in more cities [3]. JD Health's Competitive Edge - JD Health operates its own offline pharmacies, which provides it with a supply chain advantage over Meituan. This model may be more suitable for the healthcare sector, where offline services are crucial [4]. - The report highlights that JD Health could outperform revenue growth expectations due to strong drug sales and gross profit margin expansion [5]. Market Outlook - The internet healthcare space is viewed positively due to its high growth visibility and potential catalysts such as AI and consumption recovery. Both JD Health and Meituan are expected to benefit from these trends [5].

Summary of JD.com Conference Call Company Overview - **Company**: JD.com (JD.OQ, JD US) - **Industry**: Media & Internet, specifically e-commerce in China Key Financial Highlights - **1Q25 Performance**: - Non-GAAP EPS increased by 49% year-over-year, exceeding Bloomberg consensus by 25% and internal forecasts by 15% [1] - Revenue grew by 16% year-over-year, surpassing the consensus estimate of 12% growth by 4% [1] - **FY25 Revenue Guidance**: - Raised from "high-single-digit percent" growth to "double-digit percent" growth, driven by JD Retail's expected revenue growth [1] - **Earnings Outlook**: - Management expressed caution regarding FY25 earnings, retracting previous guidance of high-single-digit percent growth in net profit due to necessary investments in the food delivery (FD) business [1][3] Investment in Food Delivery Business - **Commitment to FD**: - JD is committed to investing in the FD business, viewing it as a strategic initiative to build its on-demand retail (ODR) business and defend against competition from Meituan [2] - **Financial Impact**: - Expected operating loss from new businesses, including FD, to reach CNY 11 billion in FY25, compared to a loss of CNY 3.4 billion in FY24 [3] Revenue and Profit Projections - **Revised Projections**: - FY25F revenue projected at CNY 1,299,262 million, a 3% increase from previous estimates [18] - Non-GAAP net profit for FY25F revised down to CNY 46,930 million, a 10% decrease from earlier projections [18] - **JD Retail Performance**: - Anticipated revenue growth of 12% year-over-year and operating profit growth of 19% [3] Shareholder Returns - **Share Repurchase**: - JD has repurchased USD 1.5 billion worth of shares year-to-date, accounting for 2.8% of its market cap [3] - **Target Price**: - Target price lowered to USD 52 from USD 55, reflecting a 30% discount on JD's cash balance to account for FD investments [3][4] Market Position and Valuation - **Current Market Cap**: Approximately USD 53.99 billion [4] - **Stock Valuation**: - Currently trading at 8.8x FY25F P/E, with an implied upside of 39.6% based on the new target price [4] Risks and Considerations - **Downside Risks**: - Potential risks include further deterioration of the macroeconomic environment and weaker margin ramp-up for JD Retail and/or JD Logistics [12][38] Additional Insights - **E-commerce Model**: - JD operates primarily on a first-party (1P) model, providing marketplace and advertising services to third-party merchants [11] - **Logistics Services**: - JD Logistics offers comprehensive logistics services, which are integral to its retail ecosystem [11] This summary encapsulates the key points from the JD.com conference call, highlighting financial performance, strategic investments, market positioning, and potential risks.